1 / 7

Thalassemia Treatment Market 2020 Trends, Size, Growth, Segments, Supply, Demand and Regional Study by Forecast to 2025

Thalassemia Treatment Market is expected to cross USD 3763 Million by 2025 at a CAGR of 10.4%.

aditi3019
Download Presentation

Thalassemia Treatment Market 2020 Trends, Size, Growth, Segments, Supply, Demand and Regional Study by Forecast to 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thalassemia Treatment Market 2020-2025 Industry Survey, Growth, Competitive Landscapeand Forecasts to 2025 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Thalassemia Treatment Market 2020-2025 Thalassemia Treatment Market Highlights Click to add text According to MRFR analysis, Thalassemia Treatment Market is expected to register a CAGR of 10.4% during the forecast period of 2019 to 2025 and was valued at USD 1890.4 Million in 2018. Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia. The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. Click to add text Click to add text www.marketresearchfuture.com

  3. Thalassemia Treatment Market 2020-2025 Thalassemia Treatment Market Regional Analysis • The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of thalassemia and rising per capita healthcare expenditure. The thalassemia treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European thalassemia treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The thalassemia treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/thalassemia-treatment-market-8595 Click to add text www.marketresearchfuture.com

  4. Thalassemia Treatment Market 2020-2025 Thalassemia Treatment Market Segmental Analysis • The Global Thalassemia Treatment Market has been segmented based on type, treatment, and end-user. • The market, based on type, has been divided into alpha-thalassemia and beta-thalassemia. The alpha-thalassemia segment is likely to be the fastest during the forecast period as there is an increased incidence of alpha-globin disorders in the US and other Western nations. • The global thalassemia treatment market has been segmented based on treatment, into blood transfusions, iron chelation therapy, folic acid supplements, gene therapy, and bone marrow transplants. The blood transfusions segment is expected to be the fastest market as low risks are involved due to careful blood screening. For instance, about 56,000 population have major thalassemia, and there are at least 30,000 people that need regular blood transfusions to survive and 5,500 die perinatally due to alpha-thalassemia major. www.marketresearchfuture.com

  5. Thalassemia Treatment Market 2020-2025 Thalassemia Treatment MarketKey Players • Novartis AG (Switzerland), • Kiadis Pharma (Netherlands),  • Sangamo Therapeutics (US), • Gamida Cell (Israel),  • Acceleron Pharma, Inc. (US), • CELGENE CORPORATION (US),  • Bluebird Bio, Inc. (US) • Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/8595 Click to add text www.marketresearchfuture.com

  6. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  7. MARKET RESEARCH FUTURE THANK YOU sales@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related